External catheter with antiseptic agent

• US 8,491,552 B2
• Filed: 09/25/2006
• Issued: 07/23/2013
• Est. Priority Date: 09/25/2006
• Status: Active Grant

• Current Assignee: Colorado Catheter Company, Inc.
• Original Assignee: Adapta Medical, Inc.
• Inventors: House, Jamie Glen
• Primary Examiner(s): Zalukaeva, Tatyana
• Assistant Examiner(s): Hanrahan, Benedict L
• Application Number:
  US11/526,052
• Publication Number:
  US 20080077099A1
• Time in Patent Office: 2,493 Days
• Field of Search: 604/317, 604/327, 604/346, 604/347, 604349-353, 604/355
• US Class Current: 604/349
• CPC Class Codes: A61F 5/453 for collecting urine or other discharge from male member A61F6/04 takes precedence ; devices for taking sperm samples A61B10/0058

Abstract

An external catheter device is disclosed which prevents infection arising from bacterial and/or yeast growth within the external catheter. To achieve such result, the external catheter device is coated with an antiseptic agent that is able to effectively kill and prevent the growth of bacteria and yeast. Additionally, the external catheter device may have an adhesive agent coating on its inner surface to prevent the condom from shifting while on the patient'"'"'s penis.

Claims

1. An external catheterization device, the device comprising:

an ensheathing condom having a first portion adapted for surrounding a shaft of a penis, and a second portion adapted for surrounding a head of the penis;

wherein the ensheathing condom contains a combination of an antiseptic agent and an adhesive agent on a first interior surface of the first portion, and the antiseptic agent on a second interior surface of the second portion for surrounding a head of the penis,

wherein the antiseptic agent contains an anti-bacterial compound to prevent bacterial proliferation due to accumulated residual urine, the anti-bacterial compound including chlorhexidine,

wherein the adhesive compound keeps the ensheathing condom in place as the first interior surface of the first portion of the ensheathing condom fits tightly around the shaft of the penis, and

wherein the adhesive compound on the first interior surface binds with an epithelial layer of the shaft of the penis and with the first interior surface such that only the second interior surface without the adhesive comes into contact with the head of the penis.

2. The device of claim 1, wherein the anti-bacterial compound further includes nitrofurazone, silver sulfadiazine, minocycline, rifampin, or any combination thereof.

3. The device of claim 1, wherein the anti-yeast compound is composed of nystatin, fluconazole, miconazole, troconazole, ibutoconazole, or any combination thereof.

4. The device of claim 1, wherein the ensheathing condom is further comprised of an end surrounding the head of the penis and a reservoir tip for urine collection.

5. The device of claim 1, further including a connection port for directing urine out of the ensheathing condom.

6. An external catheterization device, the device comprising:

an ensheathing condom having a body adapted for surrounding a shaft of a penis, an end adapted for surrounding a head of the penis, and a reservoir tip, an adhesive agent combined with an antiseptic agent applied on a first inner surface of the body, and the antiseptic agent applied on a second inner surface of the end;

wherein the ensheathing condom is fitted over the penis such that the antiseptic agent is initially in contact with the penis and remains in contact with the penis during use, the antiseptic agent containing an anti-bacterial compound to prevent bacterial proliferation due to accumulated residual urine, the anti-bacterial compound including chlorhexidine, and

wherein the adhesive compound on the first inner surface of the body binds with an epithelial layer of the shaft of the penis and with the first inner surface such that only the second interior surface without the adhesive comes into contact with the head of the penis.

7. The device of claim 6, wherein the anti-bacterial compound further comprises nitrofurazone, silver sulfadiazine, minocycline, rifampin, or any combination thereof

8. The device of claim 6, wherein the anti-yeast compound is composed of nystatin, fluconazole, miconazole, troconazole, ibutoconazole, or any combination thereof.

9. The device of claim 6, further including a connection port for directing urine out of the ensheathing condom.

10. An external catheterization device, the device comprising:

an ensheathing condom having a body which extends over a shaft of a penis, an end surrounding a head of the penis, and a reservoir tip;

a tube connecting end; and

a tube connection port;

wherein the body, the end, and the reservoir have on their interior surfaces an antiseptic agent coating, the interior surfaces in contact with the penis during use, the antiseptic agent containing an anti-bacterial and anti-yeast compound to prevent bacterial and yeast proliferation due to accumulated residual urine, the anti-bacterial compound including chlorhexidine and being initially in contact with the penis when the ensheathing condom is fitted over the penis,

wherein the body further includes an adhesive agent combined with the antiseptic agent on a first interior surface of the body, the adhesive compound binding with an epithelial layer of the shaft of the penis and with the first interior surface such that the adhesive agent does not come into contact with the head of the penis; and

wherein the tube connection port is used to empty urine from within the reservoir and the ensheathing condom.

11. The device of claim 10, wherein the anti-bacterial compound further comprises nitrofurazone, silver sulfadiazine, minocycline, rifampin, or any combination thereof.

12. The device of claim 10, wherein the anti-yeast compound is composed of nystatin, fluconazole, miconazole, troconazole, ibutoconazole, or any combination thereof.